The treatment of adults with medulloblastoma: a prospective study.

  title={The treatment of adults with medulloblastoma: a prospective study.},
  author={Alba A Brandes and M. Ermani and Pietro Amist{\`a} and Umberto Basso and Francesca Vastola and Marina Paolo Gardiman and Paolo Iuzzolino and Sergio Turazzi and Antonino Rotilio and Lorenzo Volpin and Carlo Mazza and Laura Sainati and Franco Ammannati and Franco Berti},
  journal={International journal of radiation oncology, biology, physics},
  volume={57 3},
PURPOSE To assess in a prospective trial the value of prognostic factors and the outcome of medulloblastoma in adults. METHODS AND MATERIALS Patients (> or =18 years) with a histologic diagnosis of medulloblastoma were staged according to Chang et al.'s classification (low risk: T1, T2, T3a, M0, and no residual disease after surgery; high risk: T3b-T4, any M+ or postoperative presence of residual tumor). In low-risk patients, treatment consisted of 36 Gy to the craniospinal axis, supplemented… CONTINUE READING